Séverine Gibowski

1.4k total citations · 1 hit paper
8 papers, 137 citations indexed

About

Séverine Gibowski is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Séverine Gibowski has authored 8 papers receiving a total of 137 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 3 papers in Virology and 3 papers in Epidemiology. Recurrent topics in Séverine Gibowski's work include HIV/AIDS drug development and treatment (4 papers), HIV/AIDS Research and Interventions (3 papers) and HIV Research and Treatment (2 papers). Séverine Gibowski is often cited by papers focused on HIV/AIDS drug development and treatment (4 papers), HIV/AIDS Research and Interventions (3 papers) and HIV Research and Treatment (2 papers). Séverine Gibowski collaborates with scholars based in France. Séverine Gibowski's co-authors include Dominique Costagliola, Lambert Assoumou, Stanislas Pol, Caroline Jézequel, Sophie Métivier, Christine Katlama, Jean-Marie Chennebault, Isabelle Poizot‐Martin, Valérie Pourcher and Marc Bourlière and has published in prestigious journals such as Clinical Infectious Diseases, The Lancet Infectious Diseases and AIDS.

In The Last Decade

Séverine Gibowski

7 papers receiving 137 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Doxycycline prophylaxis and meningococcal group B vaccine to prevent bacterial sexually transmitted infections in France (ANRS 174 DOXYVAC): a multicentre, open-label, randomised trial with a 2 × 2 factorial design

2024 69 citations Jean‐Michel Molina, Béatrice Berçot et al. The Lancet Infectious Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Séverine Gibowski France	4	63	47	46	40	32	8	137
Alexandre Pérez‐González Spain	9	77 1.2×	63 1.3×	12 0.3×	15 0.4×	3 0.1×	25	178
Julie Timsit France	8	32 0.5×	116 2.5×	86 1.9×	68 1.7×	8 0.3×	9	249
Serges Tchatchouang Cameroon	8	69 1.1×	49 1.0×	8 0.2×	21 0.5×	8 0.3×	17	143
Patrick Philibert France	7	27 0.4×	106 2.3×	9 0.2×	15 0.4×	9 0.3×	19	151
Charles Bitamazire Businge South Africa	8	146 2.3×	19 0.4×	50 1.1×	10 0.3×	2 0.1×	30	226
Mustafa Önel Türkiye	9	113 1.8×	64 1.4×	29 0.6×	8 0.2×	31 1.0×	38	185
Thomas Huleux France	10	101 1.6×	116 2.5×	4 0.1×	8 0.2×	95 3.0×	18	193
F.P. Antonucci Italy	4	36 0.6×	37 0.8×	11 0.2×	4 0.1×	32 1.0×	10	77
Gaby Knecht Germany	9	108 1.7×	140 3.0×	7 0.2×	9 0.2×	92 2.9×	19	224
Jelle Koopsen Netherlands	7	114 1.8×	55 1.2×	5 0.1×	6 0.1×	113 3.5×	11	178

Countries citing papers authored by Séverine Gibowski

Since Specialization

Citations

This map shows the geographic impact of Séverine Gibowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Séverine Gibowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Séverine Gibowski more than expected).

Fields of papers citing papers by Séverine Gibowski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Séverine Gibowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Séverine Gibowski. The network helps show where Séverine Gibowski may publish in the future.

Co-authorship network of co-authors of Séverine Gibowski

This figure shows the co-authorship network connecting the top 25 collaborators of Séverine Gibowski. A scholar is included among the top collaborators of Séverine Gibowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Séverine Gibowski. Séverine Gibowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Hejblum, Gilles, Karine Amat, Sidonie Lambert-Niclot, et al.. (2025). Cost-effectiveness of a 4 days-a-week triple therapy in persons with HIV: an ancillary study of the QUATUOR trial. AIDS. 39(10). 1452–1461. 1 indexed citations

2.

Ghosn, Jade, Lambert Assoumou, Emma Rubenstein, et al.. (2024). Impact of vaccination with third generation modified vaccinia Ankara and sexual behaviour on mpox incidence in men who have sex with men: analysis among participants of the ANRS-174 DOXYVAC trial. The Lancet Regional Health - Europe. 45. 101020–101020. 2 indexed citations

3.

Abé, Emuri, Lambert Assoumou, Karine Amat, et al.. (2024). Plasma concentrations of antiretroviral drugs in a successful 4-days-a-week maintenance treatment strategy in HIV-1 patients (ANRS 170-Quatuor trial). Journal of Antimicrobial Chemotherapy. 79(6). 1380–1384.

4.

Molina, Jean‐Michel, Béatrice Berçot, Lambert Assoumou, et al.. (2024). Doxycycline prophylaxis and meningococcal group B vaccine to prevent bacterial sexually transmitted infections in France (ANRS 174 DOXYVAC): a multicentre, open-label, randomised trial with a 2 × 2 factorial design. The Lancet Infectious Diseases. 24(10). 1093–1104. 69 indexed citations breakdown →

5.

Assoumou, Lambert, Chrystèle Racine, Soraya Fellahi, et al.. (2020). Fat gain differs by sex and hormonal status in persons living with suppressed HIV switched to raltegravir/etravirine. AIDS. 34(12). 1859–1862. 8 indexed citations

6.

Abé, Emuri, Lambert Assoumou, Pierre de Truchis, et al.. (2020). Pharmacological data of a successful 4‐days‐a‐week regimen in HIV antiretroviral therapy (ANRS 162‐4D trial). British Journal of Clinical Pharmacology. 87(4). 1930–1939. 2 indexed citations

7.

Lédinghen, Victor de, Christophe Hézode, Stanislas Pol, et al.. (2017). Retreatment With Sofosbuvir Plus Grazoprevir/Elbasvir Plus Ribavirin of Patients With Hepatitis C Virus Genotype 1 or 4 Who Previously Failed an NS5A- or NS3-Containing Regimen: The ANRS HC34 REVENGE Study. Clinical Infectious Diseases. 66(7). 1013–1018. 31 indexed citations

8.

Pourcher, Valérie, Aude Desnoyer, Lambert Assoumou, et al.. (2016). Phase II Trial of Lenalidomide in HIV-Infected Patients with Previously Treated Kaposi's Sarcoma: Results of the ANRS 154 Lenakap Trial. AIDS Research and Human Retroviruses. 33(1). 1–10. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact